|
Volumn 46, Issue 6, 2008, Pages 957-958
|
Initial hospitalization and adherence to highly active antiretroviral therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPRENAVIR PHOSPHATE;
ANTIRETROVIRUS AGENT;
EFAVIRENZ;
EMTRICITABINE;
LAMIVUDINE;
LOPINAVIR;
LOPINAVIR PLUS RITONAVIR;
NEVIRAPINE;
TENOFOVIR;
ZIDOVUDINE;
ADULT;
CD4 LYMPHOCYTE COUNT;
COMBINATION CHEMOTHERAPY;
CONTROLLED STUDY;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HOSPITALIZATION;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MIDDLE AGED;
NOTE;
OUTPATIENT;
PATIENT COMPLIANCE;
QUESTIONNAIRE;
ADULT;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
FEMALE;
HIV INFECTIONS;
HIV-1;
HOSPITALIZATION;
HUMANS;
MALE;
MIDDLE AGED;
OUTPATIENTS;
PATIENT COMPLIANCE;
QUESTIONNAIRES;
|
EID: 40749136313
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/527570 Document Type: Letter |
Times cited : (4)
|
References (3)
|